Today, September 13, 2017, Emily Leonard, a US Navy veteran and UC San Diego alumna, spoke on behalf of UACT and Universities Allied for Essential Medicines before the University of California Board of Regents.  Ms. Leonard delivered a copy of the letter sent to the Regents on May 24, 2017 asking the University of California to drop its pursuit of a patent on the prostate cancer drug enzalutamide (sold by Astellas as Xtandi) in India. The Board of Regents has yet to reply to the May 24, 2017 letter, or a follow-up letter sent on August 9, 2017 to Regents member Sherry Lansing. You canRead More →

Each year, the Graduate Institute Geneva compiles the list of “300 Women Leaders in Global Health.” The list was created to “showcase female leadership in global health,” and nominations are gathered from peers to recognize women’s contributions to global health policies and initiatives. UACT is pleased to highlight the women included on the list who are involved with guiding UACT’s mission and work. Five of the incredible women included in the “300 Women Leaders in Global Health” are members of UACT’s leadership, including two members of the Board of Directors, two members of the Expert Advisory Board, as well as our Acting Director. Nominees from our BoardRead More →

On June 16, 2017, UACT delivered a letter to the Chairman and Ranking Member of the US Senate Health, Education, Labor, and Pensions (HELP) Committee regarding the soon-to-be introduced comprehensive health care bill.  In the letter to Senators Lamar Alexander and Patty Murray, UACT urged the HELP committee to hold public hearings on how the GOP-led health care reform bill will affect cancer patients. As highlighted by Sen. Murray in a HELP Committee hearing on prescription drug prices held on Tuesday June 13, 2017, the bill (which is currently being negotiated in secret) at this point is slated to be introduced and voted on withoutRead More →